Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 27;122(21):e2423077122.
doi: 10.1073/pnas.2423077122. Epub 2025 May 22.

Cancer-associated fibroblast-derived SEMA3C facilitates colorectal cancer liver metastasis via NRP2-mediated MAPK activation

Affiliations

Cancer-associated fibroblast-derived SEMA3C facilitates colorectal cancer liver metastasis via NRP2-mediated MAPK activation

Yuyuan Zhang et al. Proc Natl Acad Sci U S A. .

Abstract

Liver metastasis remains the predominant cause of mortality in patients with colorectal cancer (CRC). Nevertheless, the mechanisms underlying the initiation of colorectal cancer liver metastasis remain poorly elucidated. During the metastatic process of CRC cells from the primary site to the liver, we performed time-resolved analyses and identified a subset of tumor cells spatially located in the primary tumor and temporally distributed in the early stages of liver metastasis. These cells were termed liver metastasis-initiating cells (LMICs). LMICs exhibit high stemness, low proliferation, active interaction with surrounding stromal components, and a close association with liver metastasis. Notably, we found significant interactions between cancer-associated fibroblasts (CAFs) and LMICs via the SEMA3C-NRP2 receptor-ligand pair. Further in vivo and in vitro experiments confirmed that CAF-secreted SEMA3C could bind to the NRP2 receptor, which activates the MAPK pathway and promotes colorectal cancer liver metastasis. Our findings suggest potential therapeutic strategies for the early prevention of colorectal cancer liver metastasis.

Keywords: colorectal cancer; liver metastasis; metastasis-initiating; single-cell.

PubMed Disclaimer

Conflict of interest statement

Competing interests statement:The authors declare no competing interest.

References

    1. Shi X., et al. , Mechanism insights and therapeutic intervention of tumor metastasis: Latest developments and perspectives. Signal Transduct. Target Ther. 9, 192 (2024). - PMC - PubMed
    1. Ganesh K., Massagué J., Targeting metastatic cancer. Nat. Med. 27, 34–44 (2021). - PMC - PubMed
    1. Milette S., et al. , Molecular pathways: Targeting the microenvironment of liver metastases. Clin. Cancer Res. 23, 6390–6399 (2017). - PMC - PubMed
    1. Cañellas-Socias A., et al. , Metastatic recurrence in colorectal cancer arises from residual EMP1(+) cells. Nature 611, 603–613 (2022). - PMC - PubMed
    1. Wang Z., et al. , Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma. Neuro. Oncol. 25, 1262–1274 (2023). - PMC - PubMed

MeSH terms

LinkOut - more resources